top of page
Perspectives in Breast Cancer Pathology
by Michael Lagios, MD
Please click on title to view complete text:
Contradictory Treatment Recommendations for Ductal Carcinoma in situ (DCIS).
Risk of DCIS Recurrence by Oncotype DCIS Technology - Some Concerns.
The Clinical Significance of immunohistochemically Detectable Epithelial Cells in Sentinel Lymph Node and Bone Marrow in Breast Cancer.
Factors Influencing the Accuracy of a Core Biopsy Diagnosis of Atypical Hyperplasia. A Perspective on a Frequent Pattern.
Tamoxifen as an Adjuvant Agent for Ductal Carcinoma In Situ (DCIS)
The Breast Cancer Consultation Service
Michael D. Lagios, MD • 415-789-0965
bottom of page